Fatty acid binding protein intestinal Inhibitors (IC50, Ki)
Structure ▲ ▼ | Compound Name ▲ ▼ | Standard Type ▲ ▼ | Standard Values (in nM) ▲ ▼ |
Progesterone | Ki | 20000.0 [1] | |
Palmitic acid | IC50 | 1700.0 [1] | |
Flurbiprofen | Ki | 26000.0 [1] | |
Bezafibrate | Ki | 33000.0 [1] | |
Meclofenamic acid | Ki | 8900.0 [1] | |
Fenofibric acid | Ki | 1000.0 [1] | |
(E)-4-[(2-Methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid | Ki | 6570.0 [1] | |
3-(5-Bromo-indole-1-sulfonyl)-thiophene-2-carboxylic acid | IC50 | 3900.0 [1] | |
2-(Carbazole-9-sulfonyl)-benzoic acid | IC50 | 100000.0 [1] | |
3-(Carbazole-9-sulfonyl)-thiophene-2-carboxylic acid | IC50 | 42000.0 [1] |
References
This online tool may be cited as follows
MLA | "Quest Database™ Fatty acid binding protein intestinal Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/fatty-acid-binding-protein-intestinal-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2024, November 21). Quest Database™ Fatty acid binding protein intestinal Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/fatty-acid-binding-protein-intestinal-inhibitors-ic50-ki. | |
BibTeX | EndNote | RefMan |